1. Home
  2. BNR vs NLOP Comparison

BNR vs NLOP Comparison

Compare BNR & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$15.00

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

NLOP

Net Lease Office Properties of Beneficial Interest

HOLD

Current Price

$11.83

Market Cap

194.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
NLOP
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.7M
194.2M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
BNR
NLOP
Price
$15.00
$11.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.6K
152.5K
Earning Date
06-05-2026
05-19-2026
Dividend Yield
N/A
52.20%
EPS Growth
N/A
N/A
EPS
N/A
1.69
Revenue
N/A
$118,915,000.00
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.03
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$11.24
52 Week High
$41.72
$34.53

Technical Indicators

Market Signals
Indicator
BNR
NLOP
Relative Strength Index (RSI) 34.47 41.98
Support Level $7.99 $11.24
Resistance Level $22.50 $13.50
Average True Range (ATR) 0.88 0.41
MACD -0.10 -0.03
Stochastic Oscillator 1.67 26.60

Price Performance

Historical Comparison
BNR
NLOP

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.

Share on Social Networks: